feed,title,long_url,short_url
Benzinga,BiondVax Shares Skyrocket After It Plans To In-License Nanosized COVID-19 Antibody,https://benzinga.com/general/biotech/21/12/24736954/biondvax-shares-skyrocket-after-it-plans-to-in-license-nanosized-covid-19-antibody,https://j.mp/3qgR37I
Benzinga,Allakos' Shares Nosedive After Lirentelimab Studies Fail To Achieve Statistical Significance On Symptomatic Endpoints,https://benzinga.com/general/biotech/21/12/24736319/allakos-shares-nosedive-after-lirentelimab-studies-fail-to-achieve-statistical-significance-on-sy,https://j.mp/3Jdffk4
